Literature DB >> 2407840

Immunity targeting common core antigens of gram-negative bacteria.

J W Tyler1, J S Cullor, S J Spier, B P Smith.   

Abstract

Antibodies against common gram-negative core antigens can provide protection against environmental, commensual, and contagious bacteria that cause life-threatening gram-negative sepsis/endotoxemia. Cross-protective immunity may be effective against many common livestock diseases, including neonatal coliform septicemia, coliform mastitis, septic metritis, and severe enteritis. The greatest potential benefit of cross-protective immunity may be realized in the reduction of ill-thrift and mortality of neonates. The use of active and passive immunization against core antigens common to gram-negative bacteria has been successful in human beings, laboratory animals, and livestock. Protection has been observed following challenge with either heterologous endotoxin or unrelated, live, virulent gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407840     DOI: 10.1111/j.1939-1676.1990.tb00870.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  4 in total

1.  Chickens hyperimmunized with Escherichia coli J5 strain are protected against experimental challenge with Escherichia coli O78 serotype.

Authors:  T A Abdul-Aziz; S N el-Sukhon
Journal:  Vet Res Commun       Date:  1998-01       Impact factor: 2.459

2.  Antigenic homology of the inducible ferric citrate receptor (FecA) of coliform bacteria isolated from herds with naturally occurring bovine intramammary infections.

Authors:  J Lin; J S Hogan; K L Smith
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

3.  Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.

Authors:  Lampros Fotis; Nurmohammad Shaikh; Kevin W Baszis; Charles M Samson; Raffi Lev-Tzion; Anthony R French; Phillip I Tarr
Journal:  J Rheumatol       Date:  2017-09-15       Impact factor: 4.666

4.  Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.

Authors:  Ulrich Terheggen; Damien R Drew; Anthony N Hodder; Nadia J Cross; Cleopatra K Mugyenyi; Alyssa E Barry; Robin F Anders; Sheetij Dutta; Faith H A Osier; Salenna R Elliott; Nicolas Senn; Danielle I Stanisic; Kevin Marsh; Peter M Siba; Ivo Mueller; Jack S Richards; James G Beeson
Journal:  BMC Med       Date:  2014-10-16       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.